269 related articles for article (PubMed ID: 23474948)
21. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
22. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
[TBL] [Abstract][Full Text] [Related]
24. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
26. p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance.
Flem-Karlsen K; Tekle C; Øyjord T; Flørenes VA; Mælandsmo GM; Fodstad Ø; Nunes-Xavier CE
Sci Rep; 2019 Apr; 9(1):5839. PubMed ID: 30967582
[TBL] [Abstract][Full Text] [Related]
27. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
28. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
Liu H; Tekle C; Chen YW; Kristian A; Zhao Y; Zhou M; Liu Z; Ding Y; Wang B; Mælandsmo GM; Nesland JM; Fodstad O; Tan M
Mol Cancer Ther; 2011 Jun; 10(6):960-71. PubMed ID: 21518725
[TBL] [Abstract][Full Text] [Related]
29. MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer.
Deng M; Wu D; Zhang Y; Jin Z; Miao J
Gynecol Oncol; 2021 Jul; 162(1):190-199. PubMed ID: 33875234
[TBL] [Abstract][Full Text] [Related]
30. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.
Benzon B; Zhao SG; Haffner MC; Takhar M; Erho N; Yousefi K; Hurley P; Bishop JL; Tosoian J; Ghabili K; Alshalalfa M; Glavaris S; Simons BW; Tran P; Davicioni E; Karnes RJ; Boudadi K; Antonarakis ES; Schaeffer EM; Drake CG; Feng F; Ross AE
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):28-35. PubMed ID: 27801901
[TBL] [Abstract][Full Text] [Related]
31. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
33. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
34. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.
Aung PP; Parra ER; Barua S; Sui D; Ning J; Mino B; Ledesma DA; Curry JL; Nagarajan P; Torres-Cabala CA; Efstathiou E; Hoang AG; Wong MK; Wargo JA; Lazar AJ; Rao A; Prieto VG; Wistuba I; Tetzlaff MT
Clin Cancer Res; 2019 Jun; 25(11):3455-3467. PubMed ID: 30808776
[TBL] [Abstract][Full Text] [Related]
35. B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.
Zhou Z; Luther N; Ibrahim GM; Hawkins C; Vibhakar R; Handler MH; Souweidane MM
J Neurooncol; 2013 Feb; 111(3):257-64. PubMed ID: 23232807
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
Xu H; Cheung IY; Guo HF; Cheung NK
Cancer Res; 2009 Aug; 69(15):6275-81. PubMed ID: 19584290
[TBL] [Abstract][Full Text] [Related]
37. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
38. Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice.
Yin SJ; Wang WJ; Zhang JY
Genet Mol Res; 2015 Nov; 14(4):14253-61. PubMed ID: 26600483
[TBL] [Abstract][Full Text] [Related]
39. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
[TBL] [Abstract][Full Text] [Related]
40. B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.
Luo D; Xiao H; Dong J; Li Y; Feng G; Cui M; Fan S
Biochem Biophys Res Commun; 2017 Jan; 482(4):1246-1251. PubMed ID: 27939887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
